Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.
Journal: Blood cancer journal
Published: September 13, 2025
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.
Journal: Blood cancer journal
Published: January 11, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.
Journal: The oncologist
Published: January 06, 2025
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Journal: British journal of haematology
Published: June 13, 2024
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Journal: Bone marrow transplantation
Published: December 13, 2023
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Journal: Blood cancer journal
Published: November 30, 2023
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Journal: Haematologica
Published: June 02, 2023
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience.
Journal: Journal of cancer research and clinical oncology
Published: September 12, 2020
Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer.
Journal: The breast journal
Published: August 03, 2020
Last Updated: 09/26/2026